Peter A. Thompson - Jun 10, 2024 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Director, 10%+ Owner
Signature
/s/ John R. Moore Attorney-in-Fact for Peter Thompson M.D.
Stock symbol
EWTX
Transactions as of
Jun 10, 2024
Transactions value $
$0
Form type
4
Date filed
6/12/2024, 07:33 PM
Previous filing
May 20, 2024
Next filing
Jun 17, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Options (Right to buy) Award $0 +20.6K $0.00 20.6K Jun 10, 2024 Common Stock 20.6K $17.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the Stock Options granted on June 10, 2024 will become vested on the earlier of (i) June 10, 2025 or (ii) the business day prior to the date of the 2025 annual meeting of stockholders.